NCT06851715 Improving Quality of Life for Teenagers With Asthma
| NCT ID | NCT06851715 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital Southampton NHS Foundation Trust |
| Condition | Asthma in Children |
| Study Type | INTERVENTIONAL |
| Enrollment | 98 participants |
| Start Date | 2025-08-26 |
| Primary Completion | 2027-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 98 participants in total. It began in 2025-08-26 with a primary completion date of 2027-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
BACKGROUND: Asthma is a long-term lung condition affecting 1 in 11 children and young people in the UK. Many teenagers have well controlled asthma, but a significant number continue to experience regular symptoms and asthma attacks leading to hospitalisations. While non-adherence to medication is a factor, teenagers also face challenges like changing relationships with parents and peers, avoiding triggers like smoking, and fitting in treatment with daily life demands. Healthcare professionals (HCPs) also face difficulties in managing teenagers with asthma. A previous study, funded by Asthma + Lung UK, developed a new approach to manage teenage asthma by focusing on self-efficacy, which is how confident one feels about performing a task. Teenagers completed the Adolescent Asthma Self-Efficacy Questionnaire (AASEQ), which identified areas where they needed more support. HCPs then tailored their consultations to address these needs. This approach improved the teenagers' confidence in self-managing their asthma. Improving quality of life (QoL) is a key goal in asthma care. Therefore, the aim of this study is to determine if the self-efficacy approach improves QoL for teenagers with asthma. METHODS: Teenagers aged 12-18 years with asthma will be recruited from hospital clinics. They will be randomly assigned to one of two groups: 1. Teenager will complete the AASEQ at the start of their appointment. The HCPs will use this to focus the consultation on areas where the teenager needs support in self-managing their asthma. 2. Teenager will have their usual consultation with the HCP. Three months after the appointment, the QoL will be compared between the two groups using a standardised questionnaire. IMPACT: If the self-efficacy approach proves to be beneficial, it could help HCPs to empower teenagers to better manage their asthma and ultimately improve their quality of life.
Eligibility Criteria
Inclusion Criteria: * Adolescent aged 12-18 years * Attending a paediatric respiratory clinic * Informed consent from adolescent aged ≥16 years, and assent plus parent/guardian consent for adolescents aged ≤16 years * Paediatric Asthma Quality of Life Questionnaire score ≤5.5 points Exclusion Criteria: * Aged 0-11 or over 18 years * Other significant long-term medical condition that has a day-to-day impact on their lives (except for co-existing allergic conditions, breathing pattern disorder, dysfunctional breathing, or intermittent laryngeal obstruction) * Adolescent or parent/guardian unable to communicate sufficiently to complete consent forms.
Contact & Investigator
Anna Rattu
STUDY DIRECTOR
University of Southampton
Frequently Asked Questions
Who can join the NCT06851715 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 18 Years, studying Asthma in Children. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06851715 currently recruiting?
Yes, NCT06851715 is actively recruiting participants. Contact the research team at a.s.rattu@soton.ac.uk for enrollment information.
Where is the NCT06851715 trial being conducted?
This trial is being conducted at Southampton, United Kingdom, Isle of Wight, United Kingdom.
Who is sponsoring the NCT06851715 clinical trial?
NCT06851715 is sponsored by University Hospital Southampton NHS Foundation Trust. The principal investigator is Anna Rattu at University of Southampton. The trial plans to enroll 98 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.